J Korean Ophthalmol Soc.  2011 Mar;52(3):332-337. 10.3341/jkos.2011.52.3.332.

The Clinical Characteristics and Endovascular Management Outcomes of Dural Carotid Cavernous Fistulas

Affiliations
  • 1Department of Ophthalmology, Pusan National University School of Medicine, Busan, Korea. hychoi@pusan.ac.kr
  • 2Department of Neurology, Pusan National University School of Medicine, Busan, Korea.
  • 3Pusan National University Hospital Medical Research Institute, Busan, Korea.

Abstract

PURPOSE
To describe the clinical characteristics and endovascular management outcomes of Dural carotid cavernous sinus fistula (Dural CCF).
METHODS
Ocular symptoms, signs, and complications of 15 eyes from 14 patients confirmed with Dural CCF by angiography were examined. The medical records of patients who underwent endovascular management were analyzed retrospectively.
RESULTS
The mean age of the patients was 50.6 +/- 14.2 years; 4 were men and 10 were women. The eye consisted of 7 right eyes and 8 left eyes. Two eyes were of hypertension patients. The chief clinical symptoms on the first visit were diplopia, injection, ocular pain, proptosis, ptosis, and tinnitus. On cerebral angiography, Barrow Type D was the most common consisting of 12 cases (80%). Endovascular embolization was performed in 13 eyes and the average number of times received was 1. Signs and symptoms improved over a mean of 4.5 months of clinical follow-up in 12 eyes. There were no ocular complications related to endovascular embolization.
CONCLUSIONS
Dural CCF should be suspected in a middle-aged woman with injection or diplopia. Endovascular embolization is considered minimally invasive and highly successful for the treatment of Dural CCF.

Keyword

Carotid cavernous sinus fistula; Embolization

MeSH Terms

Angiography
Carotid-Cavernous Sinus Fistula
Caves
Cerebral Angiography
Diplopia
Exophthalmos
Eye
Female
Fistula
Follow-Up Studies
Humans
Hypertension
Male
Medical Records
Tinnitus

Reference

References

1. Grove AS Jr. The dural shunt syndrome. Pathophysiology and clinical course. Ophthalmology. 1984; 90:31–44.
2. Jang JW, Lee SY, Kim SJ. Clinical characteristics of dural cavernous sinus fistula. J Korean Ophthalmol Soc. 2000; 41:737–43.
3. Lee HJ, Lee HY, Kim SD. A case of dural carotid-cavernous sinus fistula associated with ophthalmic manifestations. J Korean Ophthalmol Soc. 1996; 37:1544–9.
4. Phelps CD, Thompson HS, Ossoinig KC. The diagnosis and prog-nosis of atypical carotid-cavernous fistula (red-eyed shunt syndrome). Am J Ophthalmol. 1982; 93:423–36.
Article
5. Stiebel-Kalish H, Setton A, Berenstein A, et al. Bilateral orbital signs predict cortical venous drainage in cavernous sinus dural AVMs. Neurology. 2002; 58:1521–4.
Article
6. Stiebel-Kalish H, Setton A, Nimii Y, et al. Cavernous sinus dural arteriovenous malformations: patterns of venous drainage are related to clinical signs and symptoms. Ophthalmology. 2002; 109:1685–91.
Article
7. Eggenberger E, Lee AG, Forget TR Jr, Rosenwasser R. A bruital headache and double vision. Surv Ophthalmol. 2000; 45:147–53.
Article
8. Procope JA, Kidwell ED Jr, Copeland RA Jr, Perry AF. Dural cavernous sinus fistula: an unusual presentation. J Natl Med Assoc. 1994; 86:363–4.
9. Lim NK, Kim JK, Kim EJ, Yoo JM. Coil embolization via a superior ophthalmic vein approach of carotid cavernous sinus fistula. J Korean Ophthalmol Soc. 2006; 47:1141–8.
10. Barrow DL, Spector RH, Braun IF, et al. Classification and treatment of spontaneous carotid-cavernous sinus fistulas. J Neurosurg. 1985; 62:248–56.
Article
11. Lie TA. Congenital anomalies of the carotid arteries, Including the carotid-basilar and carotid-vertebral anastomoses; an angiographic study and a review of the literature. Amsterdam: Excerpta Medica;2005. p. 1968.
12. Houser OW, Campbell JK, Campbell RJ, Sundt TM Jr. Arteriovenous malformation affecting the transverse dural venous sinus–an acquired lesion. Mayo Clin Proc. 1979; 54:651–61.
13. Schoolman A, Kepes JJ. Bilateral spontaneous carotid-cavernous fistulae in Ehlers-Danlos syndrome. Case report. J Neurosurg. 1967; 26:82–6.
14. Haugen OH, Sletteberg O, Thomassen L, Kråkenes J. Bilateral nontraumatic carotid cavernous sinus fistula with spontaneous closure. Acta Ophthalmol. 1990; 68:743–7.
Article
15. Mironov A. Dural arteriovenous fistula of the inferior petrosal sinus producing contralateral exophthalmus. Neuroradiology. 1994; 36:619–21.
Article
16. Martin TJ, Troost BT, Ginsberg LE, et al. Left dural to right cavernous sinus fistula. A case report. J Neuroophthalmol. 1995; 15:31–5.
Article
17. Kurata A, Miyasaka Y, Oka H, et al. Spontaneous carotid cavernous fistulas with special reference to the influence of estradiol decrease. Neurol Res. 1999; 21:631–9.
Article
18. Kim MS, Han DH, Kwon OK, et al. Clinical characteristics of dural arteriovenous fistula. J Clin Neurosci. 2002; 9:147–55.
Article
19. Kurokawa T, Katai N, Nagashima H. A case of dural carotid cavernous sinus fistula presenting contralateral eye symptoms. Folia Ophthalmol Jpn. 1995; 26:318–23.
20. Higashida RT, Halbach VV, Tsai FY, et al. Interventional neuro-vascular treatment of traumatic carotid and vertebral artery lesions: results in 234 cases. AJR Am J Roentgenol. 1989; 153:577–82.
Article
21. Berthelsen B, Svendsen P. Treatment of direct carotid-cavernous fistulas with detachable balloons. Acta Radiol. 1987; 28:683–91.
Article
22. Baek WH, Lee JS, Ha YS, et al. Treatment of traumatic car-otid-carvenous fistular using Debrun's latex detatchabel balloon. J Korean Neurosurgical Soc. 1985; 4:773–7.
23. Halbach VV, Higashida RT, Hieshima GB, et al. Transvenous embolization of direct carotid cavernous fistulas. AJNR Am J Neuroradiol. 1988; 9:741–7.
24. Quiñones D, Duckwiler G, Gobin PY, et al. Embolization of dural cavernous fistulas via superior ophthalmic vein approach. AJNR Am J Neuroradiol. 1997; 18:921–8.
25. Monsein LH, Debrun GM, Miller NR, et al. Treatment of dural car-otid-cavernous fistulas via the superior ophthalmic vein. Am J Neuroradiol. 1991; 12:435–9.
26. Cheng KM, Chan CM, Cheung YL. Transvenous embolisation of dural carotid-cavernous fistulas by multiple venous routes: a series of 27 cases. Acta Neurochir. 2003; 145:17–29.
Article
27. Chun GF, Tomsick TA. Transvenous embolization of a direct carotid cavernous fistula through the pterygoid plexus. Am J Neuroradiol. 2002; 23:1156–9.
28. Bellon RJ, Liu AY, Adler JR Jr, Norbash AM. Percutaneous transfemoral embolization of an indirect carotid-cavernous fistula with cortical venous access to the cavernous sinus. Case report. J Neurosurg. 1999; 90:959–63.
29. Urtasun F, Biondi A, Casaco A, et al. Cerebral dural arteriovenous fistulas: percutaneous transvenous embolization. Radiology. 1996; 199:209–17.
Article
30. Dawson RC 3rd, Joseph GJ, Owens DS, Barrow DL. Transvenous embolization as the primary therapy for arteriovenous fistulas of the lateral and sigmoid sinuses. Am J Neuroradiol. 1998; 19:571–6.
31. Roy D, Raymond J. The role of transvenous embolization in the treatment of intracranial dural arteriovenous fistulas. Neurosurgery. 1997; 40:1133–41. discussion 1141-4.
Article
32. Kupersmith MJ, Berenstein A, Choi IS, et al. Management of nontraumatic vascular shunts involving the cavernous sinus. Ophthalmology. 1988; 95:121–30.
Article
33. Miller NR, Monsein LH, Debrun GM, et al. Treatment of car-otid-cavernous sinus fistulas using a superior ophthalmic vein approach. J Neurosurg. 1995; 83:838–42.
Article
34. Kim C, Khwarg SI, Han MH. The clinical characteristics and treatment outcomes of dural carotid-cavernous sinus fistula. J Korean Ophthalmol Soc. 2003; 44:1463–74.
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr